Touchstone Mid Cap Growth Fund Class A (TEGAX)
Fund Assets | 1.38B |
Expense Ratio | 1.24% |
Min. Investment | $2,500 |
Turnover | n/a |
Dividend (ttm) | 1.13 |
Dividend Yield | 3.14% |
Dividend Growth | n/a |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 11, 2024 |
Previous Close | 35.41 |
YTD Return | -6.66% |
1-Year Return | 0.42% |
5-Year Return | 58.42% |
52-Week Low | 31.60 |
52-Week High | 42.57 |
Beta (5Y) | 1.14 |
Holdings | 59 |
Inception Date | Sep 30, 1994 |
About TEGAX
The investment seeks to increase the value of fund shares as a primary goal and to earn income as a secondary goal. Under normal circumstances, the fund will invest at least 80% of its assets in common stocks of mid-cap U.S. companies. A mid-cap company is defined as a company, at the time of purchase, which has a market capitalization between $1.5 billion and $12 billion or falls within the range of market capitalizations represented in the Russell Midcap® Index. The size of the companies in the Russell Midcap® Index will change with market conditions.
Performance
TEGAX had a total return of 0.42% in the past year. Since the fund's inception, the average annual return has been 12.16%, including dividends.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
Top 10 Holdings
29.74% of assetsName | Symbol | Weight |
---|---|---|
Axon Enterprise, Inc. | AXON | 4.48% |
Palantir Technologies Inc. | PLTR | 3.56% |
Vertiv Holdings Co | VRT | 3.46% |
TransDigm Group Incorporated | TDG | 3.23% |
AppLovin Corporation | APP | 2.89% |
HubSpot, Inc. | HUBS | 2.72% |
Ascendis Pharma A/S | ASND | 2.71% |
Atlassian Corporation | TEAM | 2.44% |
Ares Management Corporation | ARES | 2.16% |
DexCom, Inc. | DXCM | 2.09% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 11, 2024 | $1.12607 | Dec 11, 2024 |
Dec 9, 2022 | $0.72706 | Dec 12, 2022 |
Dec 9, 2021 | $6.37391 | Dec 10, 2021 |
Dec 10, 2020 | $2.53862 | Dec 11, 2020 |
Dec 27, 2019 | $0.00738 | Dec 30, 2019 |
Dec 11, 2019 | $2.23338 | Dec 12, 2019 |